Surveillance of hepatocellular carcinoma by medical imaging

• Verfasst von: Dietrich, Christoph F. [VerfasserIn]
• Verfasst von: Teufel, Andreas [VerfasserIn]
• Titel: Surveillance of hepatocellular carcinoma by medical imaging
• Verf.angabe: Christoph F. Dietrich, Andreas Teufel, Claude B. Sirlin, Yi Dong
• Jahr: 2019
• Umfang: 7 S.
• Fussnoten: Accepted for publication Oct 05, 2019 ; Gesehen am 07.02.2020
• Titel Quelle: Enthalten in: Quantitative imaging in medicine and surgery
• Ort Quelle: Hong Kong : AME Publ., 2011
• Jahr Quelle: 2019
• Band/Heft Quelle: 9(2019), 11, Seite 1904-1910
• ISSN Quelle: 2223-4306
• DOI: doi:10.21037/qims.2019.10.04
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1689621567

Abstract

Effective treatments for early-stage hepatocellular carcinoma (HCC) have provided the rationale for HCC surveillance since detection of the disease at an early stage is associated with more favorable outcome. In a prospective multi-institutional diagnostic study, Park et al . (1) evaluated the added value of (perfluorobutane) contrast-enhanced ultrasound (CEUS) when combined with conventional B-mode ultrasound (US) as an HCC surveillance tool in participants with liver cirrhosis using a single arm, intraindividual comparison study design.